CHRONIC MIGRAINE

This study looked at the long-term safety of a daily pill called atogepant for preventing migraines in people with chronic or episodic migraine. About 596 adults who had already completed a previous atogepant study took the drug for up to 156 weeks (about 3 years). The main goal …

This study tested whether injecting lidocaine plus platelet-rich plasma (PRP) into a nerve cluster in the neck (stellate ganglion block) works better than lidocaine alone for chronic migraine. 200 adults with chronic migraine took part. The main goal was to see if the combo treat…

This study looked at how well and how safely lasmiditan works for treating migraines as they happen. Researchers followed 100 people with migraine (with or without aura) who took the drug during an attack. The main goal was to see if they were pain-free after 2 hours and to track…

This study tested a gentle, non-invasive brain stimulation technique as an add-on to standard detox treatment for 60 adults with chronic migraine and medication overuse. The goal was to see if it could reduce the number of days with moderate-to-severe headaches and help people us…

This study looked at how galcanezumab, a newer migraine prevention drug, affects the brain in people with chronic migraine. Researchers used MRI scans to measure changes in brain structure over time. The goal was to learn whether the drug works inside or outside the brain, helpin…